Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project DV Kelly, L Bishop, S Young, J Hawboldt, L Phillips, TM Keough Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 146 (4), 218-226, 2013 | 210 | 2013 |
Management of complicated urinary tract infections in the era of antimicrobial resistance MS Bader, J Hawboldt, A Brooks Postgraduate medicine 122 (6), 7-15, 2010 | 179 | 2010 |
Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic S Young, L Bishop, L Twells, C Dillon, J Hawboldt, P O'Shea BMC family practice 12, 1-7, 2011 | 97 | 2011 |
The effect of smartphone interventions on patients with chronic obstructive pulmonary disease exacerbations: a systematic review and meta-analysis M Alwashmi, J Hawboldt, E Davis, C Marra, JM Gamble, WA Ashour JMIR mHealth and uHealth 4 (3), e5921, 2016 | 92 | 2016 |
The iterative convergent design for mobile health usability testing: mixed methods approach MF Alwashmi, J Hawboldt, E Davis, MD Fetters JMIR mHealth and uHealth 7 (4), e11656, 2019 | 88 | 2019 |
Alignment of Learning Objectives and Assessments in Therapeutics Courses to Foster Higher-Order Thinking Bev FitzPatrick, John Hawboldt, Daniel Doyle The American Journal of Pharmaceutical Education 79 (1), 1-8, 2015 | 63* | 2015 |
Perceptions of health care providers regarding a mobile health intervention to manage chronic obstructive pulmonary disease: qualitative study MF Alwashmi, B Fitzpatrick, E Davis, JM Gamble, J Farrell, J Hawboldt JMIR mHealth and uHealth 7 (6), e13950, 2019 | 42 | 2019 |
Perceptions of patients regarding mobile health interventions for the management of chronic obstructive pulmonary disease: mixed methods study MF Alwashmi, B Fitzpatrick, J Farrell, JM Gamble, E Davis, H Van Nguyen, ... JMIR mHealth and uHealth 8 (7), e17409, 2020 | 37 | 2020 |
Patients’ and physicians’ satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic L Bishop, S Young, L Twells, C Dillon, J Hawboldt BMC research notes 8, 1-7, 2015 | 33 | 2015 |
Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial E Davis, C Marra, JM Gamble, J Farrell, J Lockyer, JM FitzGerald, ... Trials 17, 1-8, 2016 | 30 | 2016 |
Intramuscular methotrexate-induced aseptic meningitis J Hawboldt, M Bader Annals of Pharmacotherapy 41 (11), 1906-1911, 2007 | 27 | 2007 |
Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador E Housser, M Mathews, J LeMessurier, S Young, J Hawboldt, R West Current Oncology 20 (3), 158, 2013 | 26 | 2013 |
Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study MF Alwashmi, B Fitzpatrick, E Davis, J Farrell, JM Gamble, J Hawboldt Therapeutic Advances in Respiratory Disease 14, 1753466620951044, 2020 | 25 | 2020 |
Community-acquired pneumonia in patients with diabetes mellitus: predictors of complications and length of hospital stay MS Bader, Y Yi, K Abouchehade, B Haroon, LD Bishop, J Hawboldt The American journal of the medical sciences 352 (1), 30-35, 2016 | 24 | 2016 |
Possible metoprolol-induced hyperkalemia J Hawboldt, D McGrath Journal of Pharmacy Practice 19 (5), 320-325, 2006 | 15 | 2006 |
Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus MS Bader, KA Abouchehade, Y Yi, B Haroon, LD Bishop, J Hawboldt European journal of clinical microbiology & infectious diseases 30, 881-886, 2011 | 13 | 2011 |
The iterative convergent design for mobile health usability testing: mixed methods approach. JMIR Mhealth Uhealth. 2019 Apr 26; 7 (4): e11656. doi: 10.2196/11656 MF Alwashmi, J Hawboldt, E Davis, MD Fetters | 12 | |
Pulmonary infection due to Mycobacterium malmoense in a patient with Crohn disease CD Cowan, JJ Hawboldt, M Bader The Canadian Journal of Hospital Pharmacy 62 (6), 496, 2009 | 8 | 2009 |
Disseminated intravascular coagulation and venous thromboembolism due to acute Epstein-Barr virus infection MS Bader, B Haroon, J Trahey, A Al-Musawi, J Hawboldt Infectious Diseases in Clinical Practice 19 (4), 284-285, 2011 | 7 | 2011 |
Validation of a cystic fibrosis medication knowledge questionnaire B FitzPatrick, J Hawboldt, M Jane Smith, T Lee Global Pediatric Health 4, 2333794X17719803, 2017 | 5 | 2017 |